norethindrone has been researched along with desogestrel in 64 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (15.63) | 18.7374 |
| 1990's | 26 (40.63) | 18.2507 |
| 2000's | 14 (21.88) | 29.6817 |
| 2010's | 14 (21.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Diamant, YZ; Goldstein, R; Kleinman, Y; Tadmor, OP | 1 |
| Felton, C; Godsland, IF; Patel, A; Proudler, A; Walton, C; Wynn, V | 1 |
| Fotherby, K | 1 |
| Artini, P; Coukos, G; Genazzani, AD; Genazzani, AR; Lattesa, AM; Nappi, C; Petraglia, F; Silferi, M; Volpe, A | 1 |
| Roy, S; Stanczyk, FZ | 1 |
| Anyaoku, V; Crook, D; Devenport, M; Felton, C; Godsland, IF; Lees, B; Proudler, T; Simpson, R; Wynn, V | 1 |
| Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
| Nilsson, B; von Schoultz, B | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Elstein, M; Eyong, E; Killick, SR; Priddy, AR | 1 |
| Christie, T | 1 |
| Hoppe, G | 1 |
| Bonnar, J | 1 |
| Bergamaschi, M; Facchinetti, F; Genazzani, AD; Genazzani, AR; Petraglia, F; Volpe, A | 1 |
| Kloosterboer, HJ; Turpijn, EW; Vonk-Noordegraaf, CA | 1 |
| Kuhl, H; Mehlis, W; Sandow, J; Taubert, HD; Weber, W | 1 |
| de Visser, J; van der Vies, J | 1 |
| Crook, D; Devenport, M; Godsland, IF; Wynn, V | 1 |
| Christiansen, C; Marslew, U; Munk-Nielsen, N; Nilas, L; Riis, BJ | 1 |
| Gudkova, MA; Krymskaia, ML; Kulakov, VI; Solov'eva, AD | 1 |
| Shoupe, D | 1 |
| Bounds, W; Guillebaud, J; Newman, B; Nichols, M; Robinson, G | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 2 |
| Graff-Iversen, S; Stensvold, I; Tverdal, A | 1 |
| Christensen, A; Damber, MG; Hirvonen, E; Milsom, I; Saure, A | 1 |
| Schwingl, PJ; Shelton, J | 1 |
| Diffey, B; O'Dea, K; Piers, LS; Soares, MJ | 1 |
| Rossmanith, WG; Schramm, G; Steffens, D | 1 |
| Gasser, S; Rossmanith, WG; Steffens, D; Thun, B; Wirth, U | 1 |
| Ledger, WJ; Saxena, BB; Singh, M; Singh, R; Thomas, D | 1 |
| Berg, G; Brenner, H; Kohlmeier, L | 1 |
| Bohlmann, MK; Prifti, S; Rabe, T; Rehberger-Schneider, S | 1 |
| Kaunitz, AM | 1 |
| Gibson, JM; Heald, A; Selby, PL; White, A | 1 |
| Huber, J; Killick, SR; Korver, T; Landgren, B; Obruca, A; Struijs, MJ | 1 |
| Altare, F; Buzio, C; Campagnoli, C; Sanseverino, P | 1 |
| Berenson, AB; Grady, JJ; Radecki, CM; Rickert, VI; Thomas, A | 1 |
| Harwood, B; Mishell, DR | 1 |
| Olsson, SE | 1 |
| Chen, JK; Gui, YL; He, ML; Li, LM; Yang, PJ | 1 |
| Berenson, AB; Breitkopf, CR; Grady, JJ; Rickert, VI; Thomas, A | 1 |
| Durrington, PN; Kwok, S; Laing, I; Mackness, B; Mackness, MI; McElduff, P; Morgan, J; Prais, H; Sci, FM; Selby, PL; Yates, AP | 1 |
| Anderson, S; Durrington, PN; Gibson, MJ; Heald, A; Kaushal, K; Redpath, M; Selby, PL | 1 |
| Avril, C; Bied-Damon, V; Bständig, B; Cédrin-Durnerin, I; Decanter, C; Hugues, JN; Parneix, I | 1 |
| Burkman, RT; Fisher, AC; LaGuardia, KD | 1 |
| Buono, MJ; Martin, JG | 1 |
| Carter, JR; Klein, JC; Schwartz, CE | 1 |
| Airee, A; Cobb, D; Guirguis, AB; Zingone, MM | 1 |
| Freeman, S; Shulman, LP | 1 |
| Weisberg, E | 1 |
| Abu Hashim, H; Alsherbini, W; Bazeed, M | 1 |
| Gallo, MF; Grimes, DA; Halpern, V; Lopez, LM; Nanda, K; Schulz, KF | 1 |
| Di Luca, M; Ferrero, S; Leone Roberti Maggiore, U; Remorgida, V; Scala, C; Venturini, PL | 1 |
| Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Hel, Z; Huijbregts, RP; Michel, KG | 1 |
| Callahan, R; Halpern, V; Nanda, K; Yacobson, I | 1 |
| Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y | 1 |
| Buggio, L; Frattaruolo, MP; Ottolini, F; Roberto, A; Somigliana, E; Vercellini, P | 1 |
| Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
| Barra, F; Bertucci, E; Facchinetti, F; Ferrero, S; Grandi, G; Napolitano, A; Sileo, FG | 1 |
6 review(s) available for norethindrone and desogestrel
| Article | Year |
|---|---|
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Contraceptive vaginal rings.
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estradiol; Estrogens; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norprogesterones; Patient Acceptance of Health Care; Progesterone; Progestins; Vinyl Compounds | 2001 |
Considerations for the use of progestin-only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States | 2010 |
Steroid hormones for contraception in men.
Topics: Azoospermia; Contraception; Contraceptive Agents, Male; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Humans; Levonorgestrel; Male; Norethindrone; Oligospermia; Randomized Controlled Trials as Topic; Testosterone | 2012 |
Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Incidence; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy, Ectopic; Progestins | 2015 |
Hormonal contraception in women with endometriosis: a systematic review.
Topics: Adult; Androstenes; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Humans; Norethindrone; Pelvic Pain; Progestins; Treatment Outcome | 2019 |
22 trial(s) available for norethindrone and desogestrel
| Article | Year |
|---|---|
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
A clinical overview of a new triphasic contraceptive containing gestodene.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Europe; Female; Humans; Menstrual Cycle; Multicenter Studies as Topic; New Zealand; Norethindrone; Norpregnenes; Patient Compliance; South America | 1989 |
Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
Topics: Breast; Climacteric; Desogestrel; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Flushing; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1994 |
Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
Topics: Adolescent; Adult; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstruation Disturbances; Norethindrone; Patient Compliance; Pregnancy | 1994 |
Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norethindrone; Norpregnenes; Prospective Studies; Time Factors | 1993 |
A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Topics: Administration, Oral; Climacteric; Desogestrel; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Physical Fitness; Placebos; Postmenopause; Progesterone Congeners; Sweating; Uterine Hemorrhage | 1996 |
A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
Topics: Adult; Cervix Mucus; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Endometrium; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Luteinizing Hormone; Menstrual Cycle; Norethindrone; Ovary; Progesterone; Steroids; Ultrasonography | 1997 |
[Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Double-Blind Method; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Norethindrone; Ovarian Function Tests; Ovary | 1997 |
A triphasic oral contraceptive pill, CTR-05: clinical efficacy and safety.
Topics: Adult; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Headache; Humans; Menstrual Cycle; Nausea; Norethindrone; Progesterone Congeners | 1996 |
Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial.
Topics: Adolescent; Adult; Body Mass Index; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Mestranol; Middle Aged; Norethindrone; Pregnancy; Treatment Failure; Uterine Hemorrhage; Weight Gain | 2000 |
Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis.
Topics: Cross-Over Studies; Desogestrel; Drug Interactions; Estrogens; Female; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Progestins; Somatomedins | 2000 |
Ovarian function during and after treatment with the new progestagen Org 30659.
Topics: Adult; Desogestrel; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Norethindrone; Ovary; Ovulation; Progesterone Congeners; Progestins; Ultrasonography | 2001 |
A prospective, controlled study of the effects of hormonal contraception on bone mineral density.
Topics: Adolescent; Adult; Bone Density; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Female; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Multivariate Analysis; Norethindrone; Prospective Studies | 2001 |
Effects of hormonal contraception on bone mineral density after 24 months of use.
Topics: Adolescent; Adult; Bone Density; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Time Factors | 2004 |
Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
Topics: Aryldialkylphosphatase; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Desogestrel; Drug Administration Schedule; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Insulin; Lipoproteins; Medroxyprogesterone; Middle Aged; Norethindrone; Postmenopause; Progestins; Risk Factors; Statistics, Nonparametric; Triglycerides | 2004 |
Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Topics: Blood Glucose; Cardiovascular Diseases; Desogestrel; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Postmenopause; Progestins; Risk Factors | 2005 |
Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol.
Topics: Adult; Clinical Protocols; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Norethindrone; Ovarian Follicle; Ovary; Treatment Outcome; Ultrasonography | 2007 |
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain | 2007 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
Effects of oral contraceptives on sympathetic nerve activity during orthostatic stress in young, healthy women.
Topics: Androstenes; Baroreflex; Blood Pressure; Contraceptives, Oral; Desogestrel; Estradiol; Female; Heart Rate; Humans; Lower Body Negative Pressure; Menstrual Cycle; Muscle, Skeletal; Norethindrone; Orthostatic Intolerance; Progesterone; Rest; Sympathetic Nervous System; Young Adult | 2010 |
Contraceptive vaginal ring treatment of heavy menstrual bleeding: a randomized controlled trial with norethisterone.
Topics: Adult; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menorrhagia; Norethindrone; Patient Satisfaction; Prospective Studies; Quality of Life; Young Adult | 2012 |
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies.
Topics: Adult; Aromatase Inhibitors; Calcium; Cholecalciferol; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogen Receptor Modulators; Female; Humans; Image Processing, Computer-Assisted; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Norpregnenes; Prospective Studies; Rectal Diseases; Treatment Outcome; Triazoles; Triptorelin Pamoate; Ultrasonography; Vaginal Diseases; Vitamins | 2013 |
36 other study(ies) available for norethindrone and desogestrel
| Article | Year |
|---|---|
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Desogestrel; Drug Combinations; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estriol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Prospective Studies; Time Factors; Triglycerides | 1992 |
Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Contraceptives, Oral; Desogestrel; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes | 1992 |
Potency and pharmacokinetics of gestagens.
Topics: Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat.
Topics: Animals; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Female; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Progestins; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains | 1990 |
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethynodiol Diacetate; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Middle Aged; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Triglycerides | 1990 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Binding of levonorgestrel, norethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels.
Topics: Binding, Competitive; Desogestrel; Female; Humans; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnancy; Pregnancy Trimester, Third; Sex Hormone-Binding Globulin; Testosterone | 1989 |
Pituitary-ovarian activity when switching from various monophasic pills to a triphasic pill.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Norethindrone; Norgestrel; Norpregnenes; Ovarian Follicle; Ovary; Pituitary Gland; Progesterone; Progestins | 1989 |
Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins; Norethindrone; Norgestrel; Norpregnenes; Population Surveillance; Progesterone Congeners; Prospective Studies; Risk | 1987 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |
Progesterone and progestins modulate beta-endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats.
Topics: Animals; beta-Endorphin; Desogestrel; Estradiol; Female; Hypothalamus, Middle; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Ovariectomy; Pituitary Gland; Pituitary Gland, Anterior; Progesterone; Progestins; Radioimmunoassay; Rats; Rats, Inbred Strains | 1987 |
Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
Topics: Cell Line; Cytosol; Desogestrel; Dihydrotestosterone; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnenediones; Receptors, Androgen; Receptors, Progesterone; Tritium | 1988 |
Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Norpregnenes; Rats | 1984 |
Endocrinological studies with desogestrel.
Topics: Administration, Oral; Animals; Castration; Contraceptives, Oral, Combined; Decidua; Desogestrel; Endometrium; Estrogen Antagonists; Female; Levonorgestrel; Mice; Norethindrone; Norgestrel; Norpregnenes; Ovulation; Pregnancy; Progesterone Congeners; Rabbits; Rats; Species Specificity | 1983 |
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors | 1995 |
[Clinical-physiological characteristics and hormone therapy of patients with typical form of climacteric syndrome].
Topics: Climacteric; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norgestrel; Syndrome; Time Factors | 1994 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Estradiol; Female; Health Surveys; Humans; Levonorgestrel; Lipids; Lynestrenol; Middle Aged; Norethindrone; Norway; Progesterone Congeners; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires | 1996 |
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States | 1997 |
The effect of oral contraceptive agents on the basal metabolic rate of young women.
Topics: Adult; Anthropometry; Basal Metabolism; Blood Pressure; Body Composition; Calorimetry, Indirect; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Pulse; Stimulation, Chemical; Systole | 1997 |
Effect of oral contraceptive progestins on serum copper concentration.
Topics: Adolescent; Adult; Androgen Antagonists; Cardiovascular Diseases; Contraceptives, Oral; Copper; Cross-Sectional Studies; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Progesterone Congeners; Progestins; Surveys and Questionnaires | 1998 |
Induction of estrogen receptor-alpha and -beta activities by synthetic progestins.
Topics: Animals; COS Cells; Desogestrel; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Ethinyl Estradiol; Gene Expression Regulation; Genes, Reporter; Humans; Luciferases; Norethindrone; Norethynodrel; Progesterone Congeners; Receptors, Estrogen; Transfection | 2000 |
Effect of conjugated estrogens on free IGF-I?
Topics: Desogestrel; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Norethindrone | 2001 |
Vaginal rings for contraception: endocrine parameters.
Topics: Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Endocrine Glands; Endocrine System; Estradiol; Estrogens; Ethinyl Estradiol; Family Planning Services; Hormones; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins | 1992 |
[Comparative study of the effects of three different kinds of oral contraceptives on lipoprotein and apolipoprotein metabolism].
Topics: Asia; Asia, Eastern; Biology; Cardiovascular System; China; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Desogestrel; Developing Countries; Family Planning Services; Levonorgestrel; Norethindrone; Physiology; Research | 1993 |
Pill research results in new guidance from CSM.
Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases | 1995 |
Probable drug interaction between warfarin and hormonal contraceptives.
Topics: Adult; Anticoagulants; Contraceptive Agents, Female; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Humans; International Normalized Ratio; Norethindrone; Warfarin | 2009 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Odds Ratio; Postmenopause; Progestins; Risk Assessment; Risk Factors; Sex Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Topics: Adult; Cells, Cultured; Contraceptive Agents, Female; Cytokines; Delayed-Action Preparations; Dendritic Cells; Desogestrel; Female; HIV-1; Humans; Imidazoles; Immune Tolerance; Levonorgestrel; Lymphocyte Activation; Lymphocytes; Medroxyprogesterone Acetate; Norethindrone; Oligodeoxyribonucleotides; Progestins; Toll-Like Receptor 9; Toll-Like Receptors | 2014 |
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult | 2017 |
Is Shifting to a Progestin Worthwhile When Estrogen-Progestins Are Inefficacious for Endometriosis-Associated Pain?
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Pelvic Pain; Progestins; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2018 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |